Drug Company Pushed Ineffective Pills - Tamiflu Useless

April 10, 2014

9 billion dollars. That's the amount it cost to stickpill Tamiflu in the USA in 2009, a drug pushed by its manufacturer Roche to help prevent the flu including H1N1. But it's now revealed it was accepted because of weak science. The research from the mamufacturer suggested it helped save lives. But now it's revealed Roche's studies were not strong, and a new review questions its effectiveness. These results are disturbing, as follows:

"There is no good evidence that the drug [Tamiflu] saves lives."

"There is no good evidence that it reduces hospitalizations, no good evidence that it reduces the risk of complications, no evidence that the drug will interrupt the spread of the virus, that's person to person transmission —  some of the major reasons why the drug was stockpiled."

Would our Canadian and provincial governments have made the same decision to stockpile the drug knowing this? Likely not. In fact, some may argument Canadian taxpayers should be refunded 100's of millions of dollars.

I am a proponent of medicine, but this story shows how medicine still needs to be second guessed and good judgment is always needed. Tamiflu caused a lot of unnecessary vomitting in children and adults. Next time when you consider taking the flu shot, be your own advocate and think on the same wavelength.  That vaccine is as equally ineffective and risky it seems.


Add comment

Security code